Patents expiring in 2041

US 11008622

Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof

Wellmarker Bio Co., LTD. · Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11008309

Substituted benzofuranyl and benzoxazolyl compounds and uses thereof

Karyopharm Therapeutics Inc. · Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11008382

Antibodies to oxidized phospholipids

The Regents of the University of California · Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11008589

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

The Regents of the University of California · Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11008590

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

The Regents of the University of California · Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013785

Activin receptor type IIA variants and methods of use thereof

Keros Therapeutics, Inc. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013787

Sustained release formulation of interleukin-10 for wound treatment and related methods

THE REGENTS OF THE UNIVERSITY OF COLORADO FOR AND ON BEHALF OF THE UNIVERSITY OF COLORADO DENVER · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013770

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

Iovance Biotherapeutics, Inc. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013774

Methods of heat inactivation of adenovirus

Ultragenyx Pharmaceutical Inc. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013782

Methods of treating chronic disorders with complement inhibitors

Apellis Pharmaceuticals, Inc. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013806

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014980

Transforming growth factor-beta-responsive polypeptides and their methods for use

The Regents of the University of California · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11015200

Antisense-induced exon exclusion in myostatin

Sarepta Therapeutics, Inc. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014931

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator

PRAXIS PRECISION MEDICINES, INC. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014950

Nucleotide analogs

The Regents of the University of California · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013805

Pharmaceutical compositions comprising meloxicam

AXSOME THERAPEUTICS, INC. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014965

Modulation of complement activity

RA PHARMACEUTICALS, INC. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013809

Sustained delivery formulations of risperidone compound

Indivior UK Limited · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11015205

Oligomeric vaccines from plants by S-Tag-S-protein fusions

LEIBNIZ-INSTITUT FÜR PFLANZENGENETIK UND KULTURPFLANZENFORSCHUNG · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013808

Clinical formulations

Astellas Institute for Regenerative Medicine · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11015023

Fire retardant compositions utilizing elemental sulfur

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11015204

Synthesis and structure of high potency RNA therapeutics

ARCTURUS THERAPEUTICS, INC. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014983

Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodies

Sutro Biopharma, Inc. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013803

Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013798

Orf virus-based platform for vaccine delivery

SOUTH DAKOTA BOARD OF REGENTS · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013767

Materials and methods for engineering cells and uses thereof in immuno-oncology

CRISPR THERAPEUTICS AG · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013713

Method of treatment

VANDA PHARMACEUTICALS INC. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11015211

Cardiac cell reprogramming with myocardin and ASCL1

Tenaya Therapeutics, Inc. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013740

Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

The Board of Regents of the University of Texas System · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013220

Humanized dipeptidyl-peptidase IV (DPP4) animals

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013754

Compositions and methods for treating cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013704

Compounds supports hematopoietic stem cells and red blood cells

The Board of Regents of the University of Texas System · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013743

Cancer treatments using combinations of CDK and ERK inhibitors

Biomed Valley Discoveries, Inc. · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014892

5HT1F receptor agonists and mitochondrial biogenesis

United States Government as represented by the Department of Veterans Affairs · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11016009

Method for isolating extracellular vesicles using aqueous two-phase system

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014955

Cyclic peroxides as prodrugs for selective delivery of agents

The Regents of the University of California · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013818

Library of pH responsive polymers and nanoprobes thereof

The Board of Regents of the University of Texas System · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014895

Heterocyclic urea compound, and drug composition and application thereof

CHINA PHARMACEUTICAL UNIVERSITY · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013705

Methods and compositions for supporting renal health

The Regents of the University of California · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014902

MYC G-quadruplex stabilizing small molecules and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11014921

Therapeutic compounds and methods of use thereof

Regents of the University of Minnesota · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11016093

Disease-associated antigens and methods of use thereof

The Regents of the University of California · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013791

NYVAC-based plasmodium malaria vaccine

The Government of the United States, as represented by the Secretary of the Army · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013726

Substituted pyridinone-containing trycyclic compounds, and methods using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11013707

Administration of oral methyldopa

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3159666

UTILISATIONS MEDICALES DU VIRUS DE LA VACCINE ANKARA MODIFIE (MVA) RECOMBINANT 4-1 BBL

BAVARIAN NORDIC AS [DK] · Granted Thu May 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3159588

VIRUS MVA RECOMBINANTS POUR L'ADMINISTRATION INTRATUMORALE ET/OU INTRAVEINEUSE POUR LE TRAITEMENT DU CANCER

BAVARIAN NORDIC AS [DK] · Granted Thu May 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2021099616

MASITINIB POUR LE TRAITEMENT DE LA DRÉPANOCYTOSE

AB SCIENCE [FR] · Granted Thu May 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)